首页> 外国专利> ПРИСТРІЙ 'ЛАТРАКС' SCS LEAD 1001 ДЛЯ ПРОВЕДЕННЯ СПИННОМОЗКОВОЇ СТИМУЛЯЦІЇ У ПАЦІЄНТІВ З РУХОВИМИ ТА ЧУТЛИВИМИ ПОРУШЕННЯМИ

ПРИСТРІЙ 'ЛАТРАКС' SCS LEAD 1001 ДЛЯ ПРОВЕДЕННЯ СПИННОМОЗКОВОЇ СТИМУЛЯЦІЇ У ПАЦІЄНТІВ З РУХОВИМИ ТА ЧУТЛИВИМИ ПОРУШЕННЯМИ

机译：LATRAX SCS LEAD 1001装置，用于运动和敏感性疾病患者的脊髓刺激

页面导航

摘要
著录项
相似文献

摘要

Пристрій для спинномозкової стимуляції у пацієнтів з руховими та чутливими порушенням належить до групи хірургічних імплантів, який включає генератор імпульсів (подібний до пейсмейкера), що з'єднаний гнучкими дротами з платиновими електродами, генератор пульсу, що фіксується в м'яких тканинах в попередньо сформованому "ложі", та електроди, що встановлюються епідурально на бажаному відділі спинного мозку в залежності від рівня ушкодження.

机译：用于运动和感觉障碍患者的脊柱刺激装置属于外科植入物组，该装置包括通过柔性导线连接到铂电极的脉冲发生器（类似于起搏器），脉冲发生器固定在预成型的软组织中根据损伤程度，将“床”和电极硬膜外安装在脊髓的所需部位。

著录项

公开/公告号UA138703U

专利类型
公开/公告日2019-12-10

原文格式PDF
申请/专利权人 ТОВАРИСТВО З ОБМЕЖЕНОЮ ВІДПОВІДАЛЬНІСТЮ ЛАТРАКС;
展开▼

申请/专利号UAU201905019U
发明设计人 СОКОЛ АНАТОЛІЙ АНАТОЛІЙОВИЧ;БІЛОШИЦЬКИЙ ВАДИМ ВАСИЛЬОВИЧ;ПРУНЧАК ВІКТОР ВАСИЛЬОВИЧ;ФІЛЬ ОЛЕКСІЙ МИКОЛАЙОВИЧ;ГОЙ ІРИНА МИКОЛАЇВНА;ЦИМБАЛЮК ЯРОСЛАВ ВІТАЛІЙОВИЧ;
展开▼

申请日2019-05-11
分类号
国家 UA
入库时间 2022-08-21 11:16:10

相似文献

专利
外文文献
中文文献

1. Genesis of fahlore in the Tianbaoshan lead-zinc deposit, Sichuan Province, China: a scanning electron microscopy-energy dispersive spectroscopy study [J] . Yusi Hu, Lin Ye, Zhenli Li, 中国地球化学学报（英文版） . 2018,第006期

2. Signaling Cascades Activated by UVBUVB in Human Melanocytes Lead to the Increased Expression of Melanocyte Receptors, Endothelin B Receptor and c‐ KITKIT xmlns="http://www.wiley.com/namespaces/wiley" href="#php12848-note-1001"/> [J] . Terazawa Shuko, Imokawa Genji Photochemistry and Photobiology: An International Journal . 2018,第3期

3. Lead Us (Not) into Temptation: Testing the Motivational Mechanisms Linking Honesty–Humility to Cooperation xmlns="http://www.wiley.com/namespaces/wiley" href="#per2149-note-1001"/> [J] . Hilbig Benjamin E., Kieslich Pascal J., Henninger Felix, European journal of personality . 2018,第2期

4. Coformulation of a Novel Human alpha-Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice [J] . Xu Su, Lun Yi, Brignol Nastry, Molecular therapy: the journal of the American Society of Gene Therapy . 2015,第7期

5. Mineralized E1001(1k) Scaffolds for Bone Tissue Regeneration: The Effect of Dicalcium Phosphate Dihydrate Composition on Human Dental Pulp Stem Cells [C] . Wei Chang, Shruti Saxena, Amir Fakhrzadeh, Society for Biomaterials annual meeting and exposition . 2018

6. Bound Infinities: Scheherazade's Moral Matrix of 'The 1001 Nights' [D] . Lundell, Michael James 2012

7. Coformulation of a Novel Human α-Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice [O] . Su Xu, Yi Lun, Nastry Brignol, 2015

8. P981Lvot area measurement using gated ct data reclassifies aortic stenosis severity as graded by echocardiographyP982Paradoxical low-flow low-gradient aortic stenosis: an intermediate state between moderate and severe aortic stenosis?P983Can rheumatic significant mitral stenosis be a cause of paradoxical low gradient, low flow, in patients with severe aortic stenosis? an echocardiographic and outcome studyP984Clinical and hemodynamic comparison of isolated versus combined aortic and mitral stenosisP985Echocardiographic end-diastolic velocity in the proximal descending aorta should be interpreted with caution when the ascending aorta is dilated: insights from cardiovascular magnetic resonanceP987Prevalence of atrial mitral regurgitation in patients with severe mitral regurgitationP988Role of 2D/3D echocardiography in the risk stratification of endocardial lead-related tricuspid regurgitation: a single-centre study among?241 patientsP989When TEE is needed in patients with staphylococcus aureus bacteremia for the assessment of risk profile of infective endocarditis?P990Appropriateness criteria to echocardiograms for suspected infective endocarditis: experience of a tertiary referral centerP991Independent predictors of outcome in infective endocarditisP992The role of transesophageal cardiography in clinical course and prognosis of complicated infective endocarditis in critically ill patients: our 15 years experienceP993Left bundle branch block atypical pattern as a prognostic determinant in patients taken to TAVIP994Efficacy of long-term ivabradine therapy in severe systolic chronic heart failure patients with and without type 2 diabetes mellitusP995Relations between left ventricular reverse remodeling and serum markers of extracellular matrix fibrosis in dilated cardiomyopathyP996The healthy left ventricle accommodates an increasing vortex formation time for volume transfer in diastolic filling :Implications for heart failureP997Evolutionary changes of pulmonary artery pressure after left ventricular assist device implantP998Functional correlates and prognostic value of coronary flow velocity reserve by vasodilator stress echocardiography in hypertrophic cardiomyopathyP999Quantification of myocardial performance in patients with non-obstructive versus latent-obstructive hypertrophic cardiomyopathyP1000Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessmentP1001Impact of fibrosis visualized by CMR in vectorcardiogram recordings of patients with suspected arrhythmogenic cardiomyopathyP1002Determinants of the beneficial effect of aldosterone antagonism on exercise capacity in heart failure with reduced ejection fractionP1003Myocardial strain values in patients with acute myocarditis and preserved ejection fraction. A magnetic resonance feature tracking studyP1004Detection of subclinical left ventricular dysfunction by speckle tracking echocardiography in patients with myocarditis without prominent wall motion abnormalitiesP1005Aborted sudden cardiac death patients aged <50 years show only mild alterations on cardiac magnetic resonance imagingP1006Relationships between subepicardial and subendocardial longitudinal strain with late gadolinium enhancement in uncomplicated hypertensive patients [O] . L. Moderato, C. Di Nora, A. Soufiani, 2016

1. BACKGROUND： Vibrio vulnifi cus inside the body could activate the NF-!B signaling pathwayand initiate the inflammatory cascade. The lung is one of the earliest organs affected by sepsisassociated with acute lung injury. High mobility group protein B1 （HMGB1） is an important late-actingpro-infl ammatory cytokine involving in the pathophysiology of sepsis. It is also involved in the injuryprocess in the lung, liver and intestine. There has been no report on the involvement of HMGB1 inVibrio vulnifi cus sepsis-induced lung injury.METHODS： Sixty rats were randomly divided into a normal control group （group A, n=10） anda Vibrio vulnificus sepsis group （group B, n=50）. Sepsis was induced in the rats by subcutaneousinjection of Vibrio vulnificus （concentration 6×108 cfu/mL, volume 0.1 mL/100g）） into the left lowerlimbs. The rats in group B were sacrifi ced separately 1, 6, 12, 24, and 48 hours after the infection.Their lungs were stored as specimens, lung water content was measured, and lung pathology wasobserved under a light microscope. The expressions of the HMGB1 gene and protein in the lungswere detected by RT-PCR and Western blot. Data were analyzed with one-way analysis of variance（ANOVA） and the LSD method for pair-wise comparison between the two groups. P〈0.05 wasconsidered statistically signifi cant.RESULTS： Compared to group A （0.652±0.177）, HMGB1 mRNA expression in the lungs ofgroup B was signifi cantly higher at 0 hour （1.161±0.358, P=0.013）, 24 hours （1.679±0.235, P=0.000）,and 48 hours （1.258±0.274, P=0.004）（P〈0.05）, and peaked at 24 hours. Compared to group A（0.594±0.190）, HMGB1 protein expression at 6 hours （1.408±0.567, P=0.026） after infection wassignificantly increased （P〈0. 05）, and peaked at 24 hours （2.415±1.064, P=0.000） after infection.Compared to group A （0.699±0.054）, lung water content was significantly increased at 6 hours（0.759±0.030, P=0.001）,12 hours （0.767±0.023, P=0.000）, 24 hours （0.771±0.043, P=0.000） and 48hours （0.789±0.137, P=0.000） after infection （P〈0.05）. Compared to group A, pathological changesat 12 hours in group B indicate marked pulmonary vascular congestion, interstitial edema andinfl ammatory infi ltration. Alveolar cavity collapse and boundaries of the alveolar septum could not beclearly identifi ed.CONCLUSION： Vibrio vulnifi cus sepsis can lead to injury in rat lungs, and increased HMGB1expression in lung tissue may be one of the mechanisms for injury from Vibrio vulnifi cus sepsis. [J] . Qiao-meng Qiu ,Zhong-wang Li ,Lu-ming Tang . 世界急诊医学杂志(英文) . 2011,第4期

2. Investigation　on　Phase　Transition　of　Ferroelectric　Ceramics　of　Lead　Titanate─Zirconate　Doped　with　Niobium　and　Tin─Substituted　Lead　Titanate─Zirconate　by　DTA，DSC　and　PRD [J] . $$$$Lu Changwei ,Xi Tonggeng ,Yang Xuehua . 化学世界 . 1996,第S1期

3. Researches on Mischmetal Preventing Lead Segregation in High Lead Bronze [J] . 李道韫 ,徐连棠 ,战松江 . 稀土学报：英文版 . 1991,第2期

4. Acupuncture-Moxibustion to Lead an All-dimensional,Multitiered and Cross-sector Development Pattern of Traditional Chinese Medicine——WFAS 2020 International Symposium on Acupuncture-Moxibustion10th Anniversary of the Inscription of Acupuncture and Moxibustion of Traditional Chinese Medicine in UNESCO Representative List of Intangible Cultural Heritage of Humanity Was Successfully Held [J] . Liu Jingyuan ,无 . 国际交流：英文版 . 2020,第003期

5. 用于脊髓损伤的植入式振荡电场刺激器研制及有效性和安全性评估 [C] . 白金柱 ,洪毅 ,霍小林 . 第三届全国脊髓损伤治疗与康复研讨会 . 2012

6. 不同频率重复经脊髓磁刺激对急性脊髓损伤大鼠运动功能的影响 [A] . 向武 . 2019